Congenital CMV infection in a Brazilian neonatal intensive care unit: high prevalence among twin newborns.

Autor: Marin LJ; Laboratório de Farmacogenômica e Epidemiologia Molec ular, Departamento de Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil. ljmarin@uesc.br., Dos Santos PR; Laboratório de Farmacogenômica e Epidemiologia Molec ular, Departamento de Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil., Ramos FC; Faculdade de Medicina, Departamento de Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil., Dos Santos UR; Laboratório de Imunobiologia, Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil., Marques M; Faculdade de Medicina, Departamento de Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil., de Carvalho LD; Laboratório de Microbiologia, Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil., Gadelha SR; Laboratório de Farmacogenômica e Epidemiologia Molec ular, Departamento de Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus, Bahia, Brasil., Aquino VH; Departamento de Inmunología, Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Central, Paraguay. vhaquino@iics.una.py.

Publikováno v: Virology journal [Virol J] 2024 Mar 08; Vol. 21 (1), pp. 63. Date of Electronic Publication: 2024 Mar 08.

Taming the SARS-CoV-2-mediated proinflammatory response with BromAc ^® .

Autor: Ferreira GM; Laboratório de Virologia Básica e Aplicada (LVBA), Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Clarindo FA; Laboratório de Virologia Básica e Aplicada (LVBA), Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Ribeiro ÁL; Laboratório de Virologia Básica e Aplicada (LVBA), Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Gomes-de-Pontes L; Laboratório de Virologia Básica e Aplicada (LVBA), Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., de Carvalho LD; Departamento de Biologia e Biotecnologia de Microrganismos, Universidade Estadual de Santa Cruz (UESC), Ilhéus, Brazil., Martins-Filho OA; Grupo Integrado de Pesquisas em Biomarcadores, Rene Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Brazil., da Fonseca FG; Laboratório de Virologia Básica e Aplicada (LVBA), Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Centro de Tecnologia em Vacinas (CT-Vacinas), Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil., Teixeira MM; CT Terapias Avançadas e Inovadoras (CT-Terapias), Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Sabino AP; Laboratório de Hematologia Clínica, Experimental e Molecular, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Eapen MS; Research & Development Department, Mucpharm Pty Ltd, Sydney, NSW, Australia., Morris DL; Research & Development Department, Mucpharm Pty Ltd, Sydney, NSW, Australia.; St George and Sutherland Hospital Clinical School, University of New South Wales, Sydney, NSW, Australia.; Department of Surgery, St George Hospital, Sydney, NSW, Australia., Valle SJ; Research & Development Department, Mucpharm Pty Ltd, Sydney, NSW, Australia.; St George and Sutherland Hospital Clinical School, University of New South Wales, Sydney, NSW, Australia.; Intensive Care Unit, St George Hospital, Sydney, NSW, Australia., Coelho-Dos-Reis JGA; Laboratório de Virologia Básica e Aplicada (LVBA), Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; CT Terapias Avançadas e Inovadoras (CT-Terapias), Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Dec 13; Vol. 14, pp. 1308477. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).

Chlorhexidine-Containing Electrospun Polymeric Nanofibers for Dental Applications: An In Vitro Study.

Autor: de Carvalho LD; Department of Oral Health Sciences, Division of Restorative Dentistry, Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada., Peres BU; Department of Oral Biological and Medical Sciences, Division of Biomaterials, Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada., Shen Y; Department of Oral Health Sciences, Division of Endodontics, Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada., Haapasalo M; Department of Oral Health Sciences, Division of Endodontics, Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada., Maezono H; Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka Dental University, Osaka 565-0871, Japan., Manso AP; Department of Oral Health Sciences, Division of Restorative Dentistry, Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada., Ko F; Department of Materials Engineering, Faculty of Applied Sciences, University of British Columbia, 309-6350 Stores Road, Vancouver, BC V6T 1Z4, Canada., Jackson J; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 East Mall, Vancouver, BC V6T 1Z3, Canada., Carvalho RM; Department of Oral Biological and Medical Sciences, Division of Biomaterials, Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2023 Sep 06; Vol. 12 (9). Date of Electronic Publication: 2023 Sep 06.

Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.

Autor: Coelho Dos Reis JGA; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil. Electronic address: jreis@icb.ufmg.br., Ferreira GM; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Lourenço AA; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Ribeiro ÁL; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., da Mata CPDSM; Risoleta Tolentino Neves Hospital, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., de Melo Oliveira P; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Marques DPA; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Ferreira LL; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Clarindo FA; Basic and Applied Virology Laboratory, Department of Microbiology, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., da Silva MF; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Filho HPP; Hospital de Ilhéus, Ilhéus, BA, Brazil., Oliveira NRR Jr; Hospital de Ilhéus, Ilhéus, BA, Brazil., Sodré MMD; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Gadelha SR; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Albuquerque GR; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil; Department of Agricultural and Environmental Sciences (DCAA), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Maciel BM; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Mariano APM; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Silva MM; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Fontana R; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Marin LJ; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil; Department of Health Sciences (DCS), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Carlos RSA; Department of Agricultural and Environmental Sciences (DCAA), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Lopes ATS; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Ferreira FB; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Dos Santos UR; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil., Santana ÍTS; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Fehlberg HF; Laboratory of Pharmacogenomics and Molecular Epidemiology (LAFEM), Santa Cruz State University (UESC), Ilhéus, BA, Brazil., Rezende RP; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil., Dias JCT; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil., Gross E; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil., Goulart GAC; Department of Pharmaceuticals, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil., Santiago MG; Department of Pharmaceuticals, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil., de Lemos APML; Hospital de Ilhéus, Ilhéus, BA, Brazil., da Conceição AO; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil., Romano CC; Hospital de Ilhéus, Ilhéus, BA, Brazil., de Carvalho LD; Department of Biological Sciences, Santa Cruz State University, Ilhéus, BA, Brazil., Martins Filho OA; Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fiocruz Minas, Belo Horizonte, MG, Brazil., Quadros CA; São Rafael Hospital and Bahia State University, Salvador, Bahia, Brazil., Morris DL; Mucpharm Pty Ltd, Sydney, NSW, Australia; University of New South Wales, St George & Sutherland Hospital Clinical School, Sydney, NSW, Australia; Department of Surgery, St George Hospital, Sydney, NSW, Australia. Electronic address: david.morris@unsw.edu.au., Valle SJ; Mucpharm Pty Ltd, Sydney, NSW, Australia; University of New South Wales, St George & Sutherland Hospital Clinical School, Sydney, NSW, Australia. Electronic address: sarah@mucpharm.com.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Apr; Vol. 148, pp. 112753. Date of Electronic Publication: 2022 Feb 25.

A Murine Model of Mycobacterium kansasii Infection Reproducing Necrotic Lung Pathology Reveals Considerable Heterogeneity in Virulence of Clinical Isolates.

Autor: Mussi VO; Laboratory of Biology of Recognition, State University of North Fluminense, Campos, Brazil., Simão TLBV; Laboratory of Biology of Recognition, State University of North Fluminense, Campos, Brazil., Almeida FM; Laboratory of Biology of Recognition, State University of North Fluminense, Campos, Brazil., Machado E; Laboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., de Carvalho LD; National Reference Laboratory for Tuberculosis, Reference Center Professor Helio Fraga, National School of Public Health, Fiocruz, Rio de Janeiro, Brazil., Calixto SD; Laboratory of Biology of Recognition, State University of North Fluminense, Campos, Brazil., Sales GAM; Laboratory of Biology of Recognition, State University of North Fluminense, Campos, Brazil., Carvalho ECQ; Laboratory of Animal Morphology and Pathology, State University of North Fluminense, Campos, Brazil., Vasconcellos SEG; Laboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., Catanho M; Laboratory of Molecular Genetics of Microorganisms, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., Suffys PN; Laboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil., Lasunskaia EB; Laboratory of Biology of Recognition, State University of North Fluminense, Campos, Brazil.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2021 Aug 24; Vol. 12, pp. 718477. Date of Electronic Publication: 2021 Aug 24 (Print Publication: 2021).